Transave's Series C Round

Transave raised a round of funding on June 15, 2006.

Transave is a biotechnology company whose mission is to improve the treatment of serious lung diseases through the development of novel site-specific liposomal drug products. The company's liposomal …

Articles about Transave's Series C Round: